A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Clinical trial NCT07489599 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07489599
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)

Start date: 2026-03-01
Primary completion: 2027-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.